BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15860833)

  • 1. Reduction in mortality from breast cancer: fall in use of hormones could have reduced breast cancer mortality.
    Grant EC
    BMJ; 2005 Apr; 330(7498):1024; author reply 1025. PubMed ID: 15860833
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pronounced differences in the estimation of breast cancer mortality in connection with hormone replacement therapy and mammographic screening].
    Jørgensen KJ
    Ugeskr Laeger; 2004 Apr; 166(15-16):1465. PubMed ID: 15146820
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
    Schierbeck LL; Rejnmark L; Tofteng CL; Stilgren L; Eiken P; Mosekilde L; Køber L; Jensen JE
    BMJ; 2012 Oct; 345():e6409. PubMed ID: 23048011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone replacement therapy (HRT) in peri- and postmenopause. Is it also allowed after treatment of breast carcinoma?].
    Graf H; Retzke U
    Zentralbl Chir; 1998; 123 Suppl 5():151-5. PubMed ID: 10063602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol, postmenopausal hormones, and breast cancer.
    Gallus S; Franceschi S; La Vecchia C
    Ann Intern Med; 2003 Oct; 139(7):601-2. PubMed ID: 14530240
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer survival and the use of HRT.
    Baum M
    Breast; 2005 Jun; 14(3):178-80. PubMed ID: 15927826
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study.
    Ewertz M; Mellemkjaer L; Poulsen AH; Friis S; Sørensen HT; Pedersen L; McLaughlin JK; Olsen JH
    Br J Cancer; 2005 Apr; 92(7):1293-7. PubMed ID: 15785751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study.
    Gottschau M; Kjær SK; Settnes A; Aalborg GL; Bens A; Jensen A; Munk C; Mellemkjær L
    Breast Cancer Res Treat; 2020 Jun; 181(2):475-485. PubMed ID: 32328847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy in peri- and postmenopausal women and breast cancer risk].
    Buchholz S; Horn F; Ortmann O
    Ther Umsch; 2008 Apr; 65(4):231-4. PubMed ID: 18622916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Bundred NJ; Morris J
    Lancet; 2003 Oct; 362(9392):1329; author reply 1330-1. PubMed ID: 14575987
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy.
    Stahlberg C; Pedersen AT; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Møller S; Rank F; Ottesen B; Lynge E
    Br J Cancer; 2004 Aug; 91(4):644-50. PubMed ID: 15238982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Danish Nurse Cohort Study 1993-2003].
    Hundrup YA; Obel EB; Rasmussen NK; Grønbaek M
    Ugeskr Laeger; 2004 Apr; 166(15-16):1451-4. PubMed ID: 15146817
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Nyirjesy I
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575990
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer rate after oophorectomy: A Prospective Danish Cohort Study.
    Koch T; Jørgensen JT; Christensen J; Dehlendorff C; Priskorn L; Simonsen MK; Duun-Henriksen AK; Andersen ZJ; Juul A; Bräuner EV; Hickey M
    Int J Cancer; 2021 Aug; 149(3):585-593. PubMed ID: 33729548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and breast cancer: estimate of risk.
    Coombs NJ; Taylor R; Wilcken N; Boyages J
    BMJ; 2005 Aug; 331(7512):347-9. PubMed ID: 16081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer in postmenopausal women after hormone therapy.
    Baber R
    JAMA; 2011 Feb; 305(5):466; author reply 466-7. PubMed ID: 21285421
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary on 'Hormone replacement therapy use and variations in the risk of breast cancer'.
    Suissa S; Opatrny L
    BJOG; 2008 Jun; 115(7):918. PubMed ID: 18485173
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone therapy and breast cancer].
    Olsen J
    Ugeskr Laeger; 2003 Sep; 165(38):3631-2. PubMed ID: 14556398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.